Joel Schwartz, M.D.
Guy Adami, Ph.D.
Chief Scientific Advisor, Founder
Dr. Guy Adami received his Ph.D. in Molecular Biology at the University of Connecticut Health Center and carried out his post-doctoral research in gene expression and cellular aging at Rockefeller University and Baylor College of Medicine respectively. He joined the University of Illinois at Chicago College of Dentistry in 1994 where he is now an Associate Professor. Dr. Adami’s expertise over the last 20 years has focused on the measurement of gene expression on the RNA level and he has collaborated with Dr. Schwartz on oral cancer since 2006. Dr. Adami’s major area of this focus is the development of noninvasive techniques for gene expression analysis of OSCC – in particular to optimize methods for the analysis of RNA levels. Dr. Adami used a hamster model for his initial work and then went on to show the value of RNA from brush oral cytology to identify OSCC in humans, where he was able to identify a 5-gene classifier for OSCC and a two distinct groups of miRNAs associated with OLP and with OSCC.
David Demirjian, Ph.D.
Dr. Demirjian is currently President and founder of zuChem, Inc. and has 25+ years of experience in developing and commercializing innovative biological technologies. He was formerly President and co-founder of ThermoGen, Inc, where he led the company until its acquisition by MediChem Life Sciences in 2000. Dr. Demirjian was a previous winner of the SBA’s Tibbett’s award for successful commercialization of technology from the SBIR program and an Ernst & Young Entrepreneur of the Year Finalist. Dr. Demirjian holds a B.S.A. from the University of Michigan and a Ph.D. from the University of Chicago.